|
⚲
|
| Keyboard |
| Mazumdar-Shaw Kiran
✚
|
|
|---|---|
| CIK # | 0002034672 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002034672] | |
| 4 | [0002034672] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Bicara Therapeutics Inc | |
| Mazumdar-Shaw Kiran |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Bicara Therapeutics Inc BCAX
Stock Option (Right to Buy) · derivative
|
2025-06-09 | Grant | 23,746 | $0.00 | |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2024-09-16 | Conversion | 4,327,365 | $0.00 | |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2024-09-16 | Conversion | 1,080,775 | $0.00 | |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2024-09-16 | Conversion | 324,552 | $0.00 | |
|
Bicara Therapeutics Inc BCAX
Series Seed Redeemable Convertible Preferred Stock · derivative
|
2024-09-16 | Conversion | 9,990,144 | $0.00 | |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2024-09-16 | Conversion | 432,736 | $0.00 | |
|
Bicara Therapeutics Inc BCAX
Series Seed Redeemable Convertible Preferred Stock · derivative
|
2024-09-16 | Conversion | 4,000,000 | $0.00 | |
|
Bicara Therapeutics Inc BCAX
Series Seed Redeemable Convertible Preferred Stock · derivative
|
2024-09-16 | Conversion | 40,000,000 | $0.00 | |
|
Bicara Therapeutics Inc BCAX
Series Seed Redeemable Convertible Preferred Stock · derivative
|
2024-09-16 | Conversion | 3,000,000 | $0.00 | |
|
Bicara Therapeutics Inc BCAX
Stock Option (Right to Buy) · derivative
|
2024-09-12 | Grant | 23,746 | $0.00 |